RESONANT INC (RESN)

Common Stock

4.48  -0.01 (-0.22%)

After market: 4.48 0 (0%)

Fundamental Rating

2

Taking everything into account, RESN scores 2 out of 10 in our fundamental rating. RESN was compared to 54 industry peers in the Communications Equipment industry. RESN has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, RESN is valued expensive at the moment.



Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year RESN has reported negative net income.
In the past 5 years RESN always reported negative net income.
RESN had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

Industry RankSector Rank
ROA -126.82%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Operating Margin and Gross Margin are not available for RESN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) -1649.86%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

More info and screens

3

2. Health

2.1 Basic Checks

The number of shares outstanding for RESN has been increased compared to 1 year ago.
The debt/assets ratio for RESN has been reduced compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of 1.08, we must say that RESN is in the distress zone and has some risk of bankruptcy.
RESN has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 1.08
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

A Current Ratio of 3.13 indicates that RESN has no problem at all paying its short term obligations.
A Quick Ratio of 3.13 indicates that RESN has no problem at all paying its short term obligations.
Industry RankSector Rank
Current Ratio 3.13
Quick Ratio 3.13

More info and screens

5

3. Growth

3.1 Past

RESN shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -1.45%.
Looking at the last year, RESN shows a very negative growth in Revenue. The Revenue has decreased by -31.01% in the last year.
RESN shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 48.66% yearly.
EPS 1Y (TTM)-1.45%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-1.68%
Revenue 1Y (TTM)-31.01%
Revenue growth 3Y61.2%
Revenue growth 5Y48.66%
Revenue growth Q2Q-12.95%

3.2 Future

The Earnings Per Share is expected to grow by 1.36% on average over the next years.
RESN is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 110.03% yearly.
EPS Next Y24.88%
EPS Next 2Y7.44%
EPS Next 3Y0.95%
EPS Next 5Y1.36%
Revenue Next Year265.95%
Revenue Next 2Y189.1%
Revenue Next 3Y169.02%
Revenue Next 5Y110.03%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for RESN. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for RESN. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -8.14

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y7.44%
EPS Next 3Y0.95%

More info and screens

0

5. Dividend

5.1 Amount

RESN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

RESONANT INC

NASDAQ:RESN (3/25/2022, 8:14:03 PM)

After market: 4.48 0 (0%)

4.48

-0.01 (-0.22%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryCommunications Equipment
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap301.01M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -126.82%
ROE N/A
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) -1649.86%
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 3.13
Quick Ratio 3.13
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-1.45%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y24.88%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-31.01%
Revenue growth 3Y61.2%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y